The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Medicinal Chemistry of Combretastatin A4: Present and Future Directions
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTMedicinal Chemistry of Combretastatin A4: Present and Future DirectionsGian Cesare Tron, Tracey Pirali, Giovanni Sorba, Francesca Pagliai, Sara Busacca, and Armando A. GenazzaniView Author Information Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center (DFBC), Università degli Studi del Piemonte Orientale "A. Avogadro", Via Bovio 6, 28100 Novara, Italy Cite this: J. Med. Chem. 2006, 49, 11, 3033–3044Publication Date (Web):April 27, 2006Publication History Received29 December 2005Published online27 April 2006Published inissue 1 June 2006https://pubs.acs.org/doi/10.1021/jm0512903https://doi.org/10.1021/jm0512903review-articleACS PublicationsCopyright © 2006 American Chemical SocietyRequest reuse permissionsArticle Views6647Altmetric-Citations553LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Aromatic compounds,Modification,Pharmaceuticals,Phenyls,Toxicity Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
The growing impact of click chemistry on drug discovery
Kolb, H. C., & Sharpless, K. B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02933-7 · Cited by 3,148
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Disrupting tumour blood vessels
Tozer, G. M., Kanthou, C., & Baguley, B. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1628 · Cited by 930
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S., & Garcia-Kendal, D. (1989) · Experientia · doi:10.1007/bf01954881 · Cited by 786
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
Anticancer Agents from Natural Products
(2005) · CRC Press eBooks · doi:10.1201/9781420039658 · Cited by 638
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark, G. G., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R., & Chaplin, D. J. (1997) · PubMed · Cited by 622
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
Wang, L., Woods, K. W., Li, Q., Barr, K. J., McCroskey, R. W., Hannick, S. M., Gherke, L., Credo, R. B., Hui, Y.-H., Marsh, K. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010523x · Cited by 422
Dowlati, A., Robertson, K., Cooney, M. M., Petros, W. P., Stratford, M. R. L., Jesberger, J. A., Rafie, N., Overmoyer, B. A., Makkar, V., Stambler, B. S., et al. (2002) · PubMed · Cited by 403
Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results
Rustin, G. J. S., Galbraith, S. M., Anderson, H., Stratford, M., Folkes, L. K., Sena, L., Gumbrell, L., & Price, P. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.185 · Cited by 307
Stevenson, J. P., Rosen, M., Sun, W., Gallagher, M., Haller, D. G., Vaughn, D., Giantonio, B., Zimmer, R., Petros, W. P., Stratford, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.986 · Cited by 291
Kanthou, C., & Tozer, G. M. (2002) · Blood · doi:10.1182/blood.v99.6.2060 · Cited by 280
Bhat, B. A., Dhar, K. L., Puri, S. C., Saxena, A. K., Shanmugavel, M., & Qazi, G. N. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.121 · Cited by 274
Hamel, E. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:38:1:1 · Cited by 272
Vincent, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24586 · Cited by 242
Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate1a,
Pettit, G. R., Toki, B. E., Herald, D. L., Verdier‐Pinard, P., Boyd, M. R., Hamel, E., & Pettit, R. K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970644q · Cited by 241
Assessment of Pharmacodynamic Vascular Response in a Phase I Trial of Combretastatin A4 Phosphate
Anderson, H. L., Yap, J. T., Miller, M. P., Robbins, A., Jones, T., & Price, P. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.186 · Cited by 217
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
Burrows, F. J., & Thorpe, P. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8996 · Cited by 198
Combretastatin A4 phosphate: background and current clinical status
Young, S. L., & Chaplin, D. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1171 · Cited by 192
Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Morinaga, Y., Akiyama, Y., & Tsuji, T. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00579-4 · Cited by 185
Novel Syntheses of Cis and Trans Isomers of Combretastatin A-4
Gaukroger, K., Hadfield, J. A., Hepworth, L. A., Lawrence, N. J., & McGown, A. T. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo015959z · Cited by 178
Simoni, D., Grisolia, G., Giannini, G., Roberti, M., Rondanin, R., Piccagli, L., Baruchello, R., Rossi, M., Romagnoli, R., Invidiata, F. P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049622b · Cited by 149
Microtubulin Binding Sites as Target for Developing Anticancer Agents
Islam, M., & Iskander, M. (2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043402946 · Cited by 146
The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
Flynn, B. L., Flynn, G. P., Hamel, E., & Jung, M. K. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00436-x · Cited by 140
Li, Q., & Sham, H. L. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.11.1663 · Cited by 133
Cooney, M. M., Radivoyevitch, T., Dowlati, A., Overmoyer, B. A., Levitan, N. I., Robertson, K., Levine, S. L., DeCaro, K., Buchter, C. M., Taylor, A. L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0364-3 · Cited by 129
Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins. Part 2
Combes, S., Barbier, P., Douillard, S., Leer, A. M., Bourgarel‐Rey, V., Pierson, J., Fedorov, A. Y., Finet, J., Boutonnât, J., & Peyrot, V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm901826e · Cited by 128
Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins
Bailly, C., Bal, C., Barbier, P., Combes, S., Finet, J., Hildebrand, M., Peyrot, V., & Wattez, N. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030903d · Cited by 124
Synthesis and Cytotoxic Evaluation of Combretafurazans
Tron, G. C., Pagliai, F., Grosso, E. D., Genazzani, A. A., & Sorba, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049096o · Cited by 117
Self-citationStructure-activity relationships for inhibition of papain by peptide Michael acceptors
Liu, S., & Hanzlik, R. P. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00084a012 · Cited by 109
Isolation, structure, and synthesis of combretastatin A-2, A-3, and B-2
Pettit, G. R., & Singh, S. B. (1987) · Canadian Journal of Chemistry · doi:10.1139/v87-399 · Cited by 101
Solladié, G., Pasturel-Jacopé, Y., & Maignan, J. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00405-8 · Cited by 95
Sheng, Y., Hua, J., Pinney, K. G., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20297 · Cited by 88
Synthesis and Cytotoxicity of 3,4-Diaryl-2(5H)-furanones
Kim, Y. D., Nam, N., You, Y., & Ahn, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00831-9 · Cited by 84
Structure-Based Discovery of a Boronic Acid Bioisostere of Combretastatin A-4
Kong, Y., Grembecka, J. E., Edler, M., Hamel, E., Mooberry, S. L., Sabat, M., Rieger, J. M., & Brown, M. L. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.06.016 · Cited by 81
Monk, K. A., Siles, R., Hadimani, M. B., Mugabe, B. E., Ackley, J. F., Studerus, S. W., Edvardsen, K., Trawick, M. L., Garner, C. M., Rhodes, M. R., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.033 · Cited by 80
Combretoxazolones: synthesis, cytotoxicity and antitumor activity
Nam, N., Kim, Y., You, Y., Hong, D.-H., Kim, H.-M., & Ahn, B. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00622-9 · Cited by 66
Nambu, H., Nambu, R., Melia, M., & Campochiaro, P. A. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0985 · Cited by 60
Nam, N., Kim, Y. D., You, Y., Hong, D.-H., Kim, H.-M., & Ahn, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00321-9 · Cited by 55
Novel sulfonate analogues of combretastatin A-4
Gwaltney, S. L., Imade, H. M., Barr, K. J., Li, Q., Gehrke, L., Credo, R. B., Warner, R. B., Lee, J. Y., Kovar, P. J., Wang, J., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00098-1 · Cited by 54
Synthesis and evaluation of double bond substituted combretastatins
Hadfield, J. A., Gaukroger, K., Hirst, N., Weston, A. P., Lawrence, N. J., & McGown, A. T. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.008 · Cited by 39
Pati, H. N., Wicks, M., Holt, H., LeBlanc, R. M., Weisbruch, P., Forrest, L. A., & Lee, M. (2005) · Heterocyclic Communications · doi:10.1515/hc.2005.11.2.117 · Cited by 38
The Discovery and Development of the Combretastatins
Cragg, G. M., Kingston, D. G. I., & Newman, D. J. (2011) · CRC Press eBooks · doi:10.1201/b11185-7 · Cited by 37
Stilbenophane Analogues of Deoxycombretastatin A-4
Mateo, C., Pérez‐Melero, C., Peláez, R., & Medarde, M. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo0508393 · Cited by 22
Cited by
An overview of tubulin inhibitors that interact with the colchicine binding site
Lu, Y., Chen, J., Xiao, M., Li, W., & Miller, D. D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0828-z · Cited by 709
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds
Ramesh, R., & Reddy, D. S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00718 · Cited by 624
Messaoudi, S., Tréguier, B., Hamze, A., Provot, O., Peyrat, J.-F., De Losada, J. R., Liu, J.-M., Bignon, J., Wdzieczak-Bakala, J., Thoret, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900321u · Cited by 287
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
Bellina, F., Cauteruccio, S., & Rossi, R. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.02.075 · Cited by 254
Fabrication of micro-cages and caged tumor spheroids for microfluidic chip-based assays
He, Y., Huang, B., Rofaani, E., Hu, J., Liu, Y., Pitingolo, G., Wang, L., Shi, J., Aimé, C., & Chen, Y. (2020) · Microelectronic Engineering · doi:10.1016/j.mee.2020.111256 · Cited by 13
Metadata
- Authors
- Tron, G. C., Pirali, T., Sorba, G., Pagliai, F., Busacca, S., & Genazzani, A. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-04-27
- Volume
- 49
- Issue
- 11
- Pages
- 3033-3044
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2145516891
- Cited by
- 629
- References
- 46
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.